Literature DB >> 11263933

Allelic deletion mapping on chromosome 6q and X chromosome inactivation clonality patterns in cervical intraepithelial neoplasia and invasive carcinoma.

R Chuaqui1, M Silva, M Emmert-Buck.   

Abstract

OBJECTIVE: Loss of heterozygosity (LOH) profiles and X chromosome inactivation patterns are analyzed in 42 patients with cervical intraepithelial neoplasias (CIN), including low-grade (CIN1) and high-grade (CIN2, CIN3) lesions, and 22 patients with invasive cervical carcinomas.
METHOD: Laser capture microdissection was utilized to procure pure matched normal and lesional cells from each case. Sixteen microsatellite markers on four chromosomal arms, 6q21-q25.1, 8p21, 13q12.3--q13, and 17q12--q21, were amplified for LOH, as well as the HUMARA locus for X chromosome inactivation analysis. Eight additional markers spanning the long arm of chromosome 6 were utilized in all cases showing LOH on this arm and in which further tissue material was available for microdissection.
RESULTS: Fifty-five percent of carcinomas showed deletions on chromosome bands 6q21--q25.1, 43% on 13q12.3--q13, and 40% on 17q12--q21. Deletions on 6q were identified in CIN3 (40%), CIN2 (37%), and CIN1 (10%), on 13q in CIN3 (33%) and CIN2 (33%), and rarely on chromosomal arm 17q. Finer 6q mapping revealed that marker D6S310 (q22) represented the centromeric and marker D6S255 (q25--q16) the telomeric boundary of deletion. A second, telomeric area of deletion at marker D6S281 (q27) was also identified. Monoclonal X chromosome inactivation patterns were identified in 12/13 cancers, 13/14 CIN3, 5/10 CIN2, and 0/6 CIN1.
CONCLUSIONS: Two areas of deletion on chromosome 6q were identified in cervical tumors, suggesting the presence of tumor suppressor gene(s) inactivated in this neoplasia. LOH on this arm were identified early during cervical tumor progression. LOH on 13q and 17q also occur in cervical cancers. X chromosome inactivation patterns suggest that CIN develops into a monoclonal lesion during progression from CIN1 to CIN3. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11263933     DOI: 10.1006/gyno.2000.6087

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

Review 1.  [Categorization of uterine cervix tumors : What's new in the 2014 WHO classification].

Authors:  S F Lax; L-C Horn; T Löning
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

2.  Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma.

Authors:  S J Mehdi; M S Alam; S Batra; M M A Rizvi
Journal:  Med Oncol       Date:  2010-07-22       Impact factor: 3.064

3.  LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastoma.

Authors:  Jacky T Yeung; Ronald L Hamilton; Koji Ohnishi; Maki Ikeura; Douglas M Potter; Marina N Nikiforova; Soldano Ferrone; Regina I Jakacki; Ian F Pollack; Hideho Okada
Journal:  Clin Cancer Res       Date:  2013-02-11       Impact factor: 12.531

4.  Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1.

Authors:  Thomas Iftner; Michaela Elbel; Betti Schopp; Thomas Hiller; Joanna I Loizou; Keith W Caldecott; Frank Stubenrauch
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

5.  Clonality analysis of synchronous lesions of cervical carcinoma based on X chromosome inactivation polymorphism, human papillomavirus type 16 genome mutations, and loss of heterozygosity.

Authors:  Xinrong Hu; Tianyun Pang; Anna Asplund; Jan Pontén; Monica Nistér
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

6.  Characterization of the Genomic Landscape in Cervical Cancer by Next Generation Sequencing.

Authors:  Ling Qiu; Hao Feng; Hailin Yu; Ming Li; Yana You; Shurong Zhu; Wenting Yang; Hua Jiang; Xin Wu
Journal:  Genes (Basel)       Date:  2022-01-31       Impact factor: 4.096

7.  Tumor derived mutations of protein tyrosine phosphatase receptor type k affect its function and alter sensitivity to chemotherapeutics in glioma.

Authors:  Supreet Agarwal; Maha S Al-Keilani; Mohammad A Y Alqudah; Zita A Sibenaller; Timothy C Ryken; Mahfoud Assem
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

8.  Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome.

Authors:  W Alazawi; M Pett; S Strauss; R Moseley; J Gray; M Stanley; N Coleman
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.